Avidity Partners Management’s Harpoon Therapeutics, Inc. Common Stock HARP Stock Holding History

Avidity Partners Management’s Portfolio HARP Stock Details HARP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-119,060	Closed	-$9.41M	–	117
2021 Q3	$9.41M	Sell	119,060 -30,940	-21%	-$3.11M	0.21%	70
2021 Q2	$20.8M	Buy	150,000 +9,200	+7%	+$1.76M	0.56%	51
2021 Q1	$29.5M	Buy	140,800 +62,300	+79%	+$12.5M	0.81%	45
2020 Q4	$13M	Sell	78,500 -38,670	-33%	-$5.98M	0.42%	61
2020 Q3	$19.9M	Sell	117,170 -3,465	-3%	-$500K	0.92%	33
2020 Q2	$20M	Buy	+120,635	New	+$18.8M	1.28%	31

Other funds holding HARP

MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return

NLVP

New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

MAM

MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

Avidity Partners Management's HARP Position: Q4 2021 in Review

Avidity Partners Management sold out of Harpoon Therapeutics, Inc. Common Stock (HARP) in Q4 2021, closing a stake of 119,060 shares — an estimated $9.41M sold.

Avidity Partners Management first reported a position in HARP in Q2 2020 and held it in 6 quarters. The position peaked at $29.5M in Q1 2021. 84 funds tracked by Wall St. Rank hold HARP as of Q4 2021.

Avidity Partners Management reported no remaining Harpoon Therapeutics, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
Avidity Partners Management sold 119,060 Harpoon Therapeutics, Inc. Common Stock shares in Q4 2021, an estimated $9.41M.
Avidity Partners Management first reported a position in Harpoon Therapeutics, Inc. Common Stock in Q2 2020 and held it in 6 quarters.
Avidity Partners Management's Harpoon Therapeutics, Inc. Common Stock position peaked at $29.5M in Q1 2021.
84 funds tracked by Wall St. Rank held Harpoon Therapeutics, Inc. Common Stock as of Q4 2021.

Based on Avidity Partners Management's 13F filing for Q4 2021, filed 14 Feb 2022.